Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alpine Immune Sciences, Inc. - Common Stock
(NQ:
ALPN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alpine Immune Sciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 24, 2021
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...
Via
Benzinga
Alpine Immune Sciences Announces First Patient Dosed in Synergy, ALPN-101 Phase 2 Lupus Clinical Trial and $45 million in Development Milestones Achieved Under AbbVie Collaboration
June 24, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs
↗
June 13, 2021
Biogen isn't the only company whose shares should benefit from a breakthrough drug.
Via
The Motley Fool
Alpine Immune Sciences Set to Join Russell 3000® Index
June 08, 2021
From
Alpine Immune Sciences, Inc
Via
Business Wire
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
↗
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Alpine Immune Sciences to Report Second Quarter 2021 Financial Results and to Present at Upcoming Investor Conferences
August 04, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 13, 2021
Gainers scPharmaceuticals (NASDAQ:SCPH) ...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 30, 2021
Gainers Ocuphire Pharma (NASDAQ:OCUP) shares increased by 63.57% to $7.77 during Wednesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Alpine Immune Sciences to Collaborate with Merck on Immuno-Oncology Study to Evaluate ALPN-202 in Combination with KEYTRUDA® (pembrolizumab)
June 30, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Announces ALPN-202 Clinical Data Presented at the 2021 ASCO Virtual Annual Meeting
June 04, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences' Autoimmune Disease Candidate ALPN-303 Shows Promise in Preclinical Studies
↗
June 03, 2021
Alpine Immune Sciences Inc (NASDAQ: ALPN) has presented the preclinical data from its ALPN-303 program at the European Alliance of Associations for Rheumatology (...
Via
Benzinga
Alpine Immune Sciences Presents ALPN-303 Data During the 2021 EULAR Virtual Meeting
June 02, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Appoints Zelanna Goldberg, M.D., M.A.S. as Chief Medical Officer
June 02, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
↗
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 20, 2021
Gainers PDS Biotechnology (NASDAQ:PDSB) shares increased by 18.99% to $6.83 during Thursday's regular session. PDS Biotechnology's stock is trading at a volume of...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
May 21, 2021
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban...
Via
Benzinga
Alpine Immune Sciences To Host Investor Event at 2021 ASCO Virtual Annual Meeting
May 19, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Announces Oral Presentation at the 2021 EULAR Virtual Meeting
May 18, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 13, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 29, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Alpine Immune Sciences to Present ALPN-202 Clinical Data at the 2021 ASCO Virtual Annual Meeting
April 28, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Presents Clinical and Preclinical Oncology Program Updates at AACR Virtual Annual Meeting I
April 12, 2021
From
Alpine Immune Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit